ARCHIVES

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Mayo Clinic Develops New Jaw Reconstruction Method

August 25, 2006

NCI-Approved CTEP Trials For The Month of June

June 29, 2012

Long-time NCI Spokesman Paul Van Nevel Dies at 75

August 9, 2013

In Brief: Durant To Leave Alabama, Will Become President, Chief Executive Officer At Fox Chase Cancer Center

September 17, 1982

The Raghavan Experiment: With $500 Million to Draw On, An Iconoclast Invents Rational Care for a Gigantic System

January 4, 2013

Lung cancer screening trial reaches accrual goal of 50,000.

January 30, 2004